×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Skip to main content
Tags: andy harris | newsmax | fda | phenylephrine

Rep. Harris to Newsmax: Probe FDA's 'Cozy Relationship' With Pharma

By    |   Wednesday, 06 December 2023 01:40 PM EST

Rep. Andy Harris, R-Md., told Newsmax on Wednesday that a "cozy relationship" between the Food and Drug Administration and pharmaceutical companies might have contributed to the agency's failure to act on a popular but ineffectual drug used for nasal decongestion.

The FDA ruled earlier this year that phenylephrine is ineffective when used as a nasal decongestant, but that came about 10 years after experts first began questioning the drug's effectiveness.

Harris, appearing on "National Report," questioned why the FDA failed to act sooner, wondering if it was due to a "cozy relationship between the FDA and some of these manufacturers."

"I don't know why the FDA took so long, the evidence has been there for over 10 years," said Harris, a former anesthesiologist and a member of the GOP Doctors Caucus. "We have to get to the bottom of why the FDA has allowed an ineffective decongestant to be available on the market for 10 years when pseudoephedrine, which is what it replaces, [is] effective [and] still available, usually behind the counter."

Harris added: "We have to find out whether there's this revolving door between the FDA and the pharmaceutical industry … the regulators who become drug company employees and vice versa, we have to find out whether that's behind it."

Theodore Bunker

Theodore Bunker, a Newsmax writer, has more than a decade covering news, media, and politics.

© 2024 Newsmax. All rights reserved.


Newsmax-Tv
Rep. Andy Harris, R-Md., told Newsmax on Wednesday that a "cozy relationship" between the Food and Drug Administration and pharmaceutical companies might have contributed to the agency's failure to act on a popular but ineffectual drug used for nasal decongestion.
andy harris, newsmax, fda, phenylephrine
211
2023-40-06
Wednesday, 06 December 2023 01:40 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
TOP

Interest-Based Advertising | Do not sell or share my personal information

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved
Download the NewsmaxTV App
Get the NewsmaxTV App for iOS Get the NewsmaxTV App for Android Scan QR code to get the NewsmaxTV App
NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved